Ischemia, Cerebral Terminated Phase 3 Trials for Ancrod (DB05099)

Also known as: Cerebral ischaemia / Cerebral Ischemia / TIA / Ischemia cerebrovascular / Ischaemia cerebral / Ischaemia cerebrovascular / Ischemia cerebral / Chronic cerebral ischemia

IndicationStatusPhase
DBCOND0083496 (Ischemia, Cerebral)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00141011Ancrod (Viprinex™) for the Treatment of Acute, Ischemic StrokeTreatment
NCT00300196ASP-II: Ancrod Stroke Program: Ancrod (Viprinex™) for the Treatment of Acute, Ischemic StrokeTreatment